Ortega-Martell JA, Huerta HRE, Huerta LJ

Idioma: Español
Referencias bibliográficas: 19
Paginas: 106-110
Archivo PDF: 222.94 Kb.

RESUMEN

La inmunoterapia de alergenos se ha practicado satisfactoriamente por alergólogos desde hace varias décadas. Esta técnica fue introducida por Leonard Noon en 1911. Él propuso que los pacientes que padecían de fiebre del heno eran sensibles a una “toxina” del polen de pasto y que podían ser beneficiados induciendo inmunidad activa a esta “toxina” por inoculaciones de un extracto de polen de pasto. La efectividad clínica en dosis adecuadas tanto en rinitis alérgica como en asma, se ha confirmado en varios trabajos. Los estudios recientes han mostrado una gran respuesta inmune anti-inflamatoria y han confirmado un efecto benéfico persistente después de un esquema adecuado de inmunoterapia.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases: a WHO position paper. J Allergy Clin Immunol 1998; 102: 558-62.

2. Noon L. Prophylactic inoculation against hay fever. Lancet 1911; 1: 1572-3.

3. Norman PS. Immunotherapy: past and present. J Allergy Clin Immunol 1998; 102: 1-10.

4. The use of standardized allergen extracts. Position statement. American Academy of Allergy, Asthma & Immunology (AAAAI). J Allergy Clin Immunol 1997: 99: 583-6.

5. Bousquet J, Van Cauwenberge P, Khaltaev N et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Workshop Report. Journal of Allergy and Clinical Immunology, Supplemental Issue, December 2001.

6. Durham SR, Till SJ. Immunologic change associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102: 157-64.

7. Frew AJ. Injection Immunotherapy. British Society for Allergy and Clinical Immunology Working Party. BMJ 1993; 307: 919-23.

8. Casanovas M, Guerra F, Moreno C, Miguel R. Double-blind placebo-controlled clinical trial of preseasonal treatment with allergenic extracts of Olea europea pollen administered sublingually. J Investig Allergol Clin Immunol 1994; 4: 305-14.

9. Giovane AL, Bardare M, Passalacqua G et al. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in pediatric patients. Clin Exp Allergy 1994; 24: 53-9.

10. Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind placebo-controlled trial of a standardized five-grass pollen extract in rhinitis. Allergy 1998; 53: 493-8.

11. Andri L, Senna G, Betteli C. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: a double-blind study. J Allergy Clin Immunol 1996; 97: 34-41.

12. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151: 969-74.

13. Bousquet J, Michel F. Specific immunotherapy in allergic rhinitis and asthma. In: Busse W, Holgate S editors. Asthma and Rhinitis. Oxford: Blackwell Scientific 1995: 1309-24.

14. International Consensus Report on Diagnosis and Management of Rhinitis. Allergy 1994; 49 Suppl 19: 1-33.

15. Durham S, Varney V, Gaga M, Frew A, Jacobson M, Kay A. Grass pollen immunotherapy remains effective 3 years after discontinuation: a double-blind, placebo-controlled withdrawal study. Clin Exp Allergy 1998; 28: 120-8.

16. Des Roches A, Paradis L, Ménardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450-3.

17. Jacobsen L, Dreborg S, Moller C et al. Immunotherapy as a preventive treatment. J Allergy Clin Immunol 1996: 97: 232.

18. Fell WR, Mabry RL, Mabry CS. Quality of life analysis of patients undergoing immunotherapy for allergic rhinitis. Ear Nose Throat J 1997; 76: 528-36.

19. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001; 108: S45-53.